-
Regorafenib Workflows for Melanoma Research
2026-09-08
Build mechanism-focused melanoma, angiogenesis, and motility assays with Regorafenib (BAY 73-4506), from controlled DMSO preparation to tumor xenograft models. The workflow connects phenotypic responses with RRM2 and ERK/E2F3 readouts, helping distinguish direct growth suppression from broader anti-invasive effects.
-
Oleanolic Acid: From Mechanism to Liposome Assays
2026-09-07
Oleanolic acid is a natural triterpenoid of interest in inducible nitric oxide synthase induction, antiviral research, and immune pathway studies. This article connects its biological profile with a decision-focused nanoparticle exclusion chromatography workflow for measuring encapsulation in dual-loaded liposomes.
-
Forskolin: Adenylate Cyclase Activator Guide
2026-09-05
Forskolin is a direct adenylate cyclase activator that elevates intracellular cAMP and supports mechanistic studies of inflammation, stem-cell biology, neuroendocrine secretion, and cardiovascular disease research. Its experimental value depends on solvent control, assay-specific dose optimization, and separation of product evidence from disease-treatment claims.
-
Perphenazine Workflows for D2 Receptor Research
2026-09-05
Perphenazine combines dopamine D2 receptor antagonism with phenothiazine polypharmacology, enabling linked workflows in neuropharmacology, mitochondrial stress biology, and macrophage host-defense research. This guide translates published findings into practical assay designs, controls, and troubleshooting checkpoints without treating exploratory data as clinical evidence.
-
Ceftazidime in Gram-Negative Resistance Research
2026-09-04
Ceftazidime provides a practical phenotype layer for studying Gram-negative susceptibility, especially Pseudomonas aeruginosa, while revealing where β-lactamase-mediated resistance limits interpretation. This workflow connects broth microdilution with plasmid, PCR, and strain-typing data from a multicenter CREC study.
-
CHK1 Inhibition in ER/PR-Stratified Breast Cancer
2026-09-04
The 2020 reference study shows that CHK1 inhibition does not produce a uniform response across breast cancer subtypes: it sensitizes ER−/PR−/HER2− models to adriamycin but has mainly single-agent activity in ER+/PR+/HER2− models. Integrated database, transcriptomic, cell-cycle, apoptosis, and drug-sensitivity analyses connect these outcomes to distinct checkpoint, mitotic, and death-signaling mechanisms.
-
MDM1, p53, and Chemoradiotherapy Sensitivity in CRC
2026-09-03
A 2025 Cancer Biology & Medicine study identifies MDM1 as a functional regulator and potential biomarker of colorectal cancer chemoradiotherapy response. Its experiments connect MDM1 overexpression with reduced YBX1 occupancy at the TP53 promoter, higher p53 expression, and stronger apoptosis after treatment, while suggesting a rationale for biomarker-guided combination strategies.
-
Perphenazine Beyond D2: A Translational Lens
2026-09-03
Perphenazine is more than a dopamine D2 receptor antagonist: its phenothiazine receptor binding profile, mitochondrial effects, opioid tolerance suppression, and emerging host-directed antibacterial activity create a mechanistic framework for translational neuropharmacology and immunology research.
-
Human iPSC Sensory Neurons Model HSV-1 Latency
2026-09-02
Oh et al. developed a scalable human induced pluripotent stem cell-derived sensory neuron system that supports measurable HSV-1 latency and reactivation. The model combines neuronal functional validation with virologic, transcriptional, and chromatin-based criteria, providing a human-relevant platform for studying neuron-intrinsic latency mechanisms.
-
Pulsed Field Ablation Remodels the Cardiac Microenvironment
2026-09-02
This study used time-resolved tissue analysis and single-nucleus sequencing to examine how pulsed field ablation changes the mouse ventricular microenvironment beyond the directly ablated myocardium. Its findings position PFA as a selective electrical ablation method that also induces coordinated stress, inflammatory, and wound-healing responses, while highlighting the need to define how these responses influence long-term cardiac repair.
-
Rapamycin (Sirolimus) Workflows for mTOR Studies
2026-09-01
Rapamycin (Sirolimus) provides a nanomolar, FKBP12-dependent way to interrogate mTOR signaling across cancer, immunology, and mitochondrial disease models. This guide translates the reference study’s pathway-validation strategy into practical dosing, assay, and troubleshooting workflows.
-
Gentamycin Sulfate: Applied Research Workflows
2026-08-31
Gentamycin Sulfate provides a practical, water-soluble aminoglycoside antibiotic platform for bacterial protein synthesis research, ribosome function analysis, and resistance-focused assay design. This guide translates a recent European non-fermenter susceptibility study into reproducible workflows, comparator strategies, and troubleshooting decisions for Gram-negative systems.
-
Podophyllotoxin: Reliable Cell Viability Workflows
2026-08-31
Learn how Podophyllotoxin, SKU N1790, can improve the interpretation and reproducibility of cell viability, cell-cycle, apoptosis, and autophagy experiments. This scenario-based guide connects formulation choices with practical assay controls and evidence from recent podophyllotoxin research.
-
HotStart Universal 2X Green qPCR Master Mix Workflow
2026-08-30
Translate diabetic foot ulcer biology into a practical RT-qPCR workflow for tracking TGF-β1, TGFBR1, VEGF, and related repair markers. This guide combines Green I signal monitoring, hot-start specificity, ROX normalization, and melt-curve verification for reproducible gene expression quantification.
-
IEM-1925 in Soman-Induced Status Epilepticus
2026-08-29
A 2026 NeuroToxicology study evaluated IEM-1925, a dual AMPA/NMDA glutamate receptor antagonist, in a rat model of soman-induced status epilepticus. The compound improved seizure control, survival, hippocampal pathology, and behavioral outcomes, while also demonstrating why receptor-level mechanism and multimodal outcome measurements matter in neurotoxicity research.